ArticleImaging neuroscience (Cambridge, Mass.)
Metabolic syndrome severity and the energetic cost of brain network transitions: A normative modeling study of accelerated brain aging.
Article in Imaging neuroscience (Cambridge, Mass.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although metabolic syndrome is a modifiable risk factor for functional decline in various organs, the brain network mechanisms linking metabolic cost to functional vulnerability remain poorly understood. We applied network control theory to diffusion magnetic resonance imaging-derived connectomes in 25,697 adults aged 40-70 years to quantify the energetic cost of engaging 8 large-scale brain networks. Metabolic syndrome was defined according to established criteria, with a composite score (0-5) based on the presence of central obesity, elevated triglycerides, reduced high-density lipoprotein cholesterol, hypertension, and impaired glycemic control. Normative modeling provided age-adjusted network deviations and brain age gap estimates. Associations with metabolic indicators and behavioral cognitive performance (7 tasks in UK Biobank) were tested, and meta-analytic mapping (123 cognitive states in Neurosynth) was used to identify at-risk domains. Severity of metabolic syndrome was associated with distinct, network-specific energetic alterations, including progressively increased subcortical control energy cost, decreased visual, and threshold changes in attentional and executive networks. The control energy profiles of the subcortical and visual networks exhibited accelerated brain age gap trajectories, reflecting significant departures from normative age-matched expectations. Waist circumference was the strongest metabolic predictor, with effects amplified in older age. Partial least squares correlation analysis revealed associations of metabolic profile (central obesity and dyslipidemia) with higher subcortical/dorsal attention/control and lower visual network energy. Vulnerability mapping indicated that episodic memory, spatial navigation, and processing speed were the domains at most at risk in relation to higher metabolic syndrome severity scores. Behavioral testing confirmed lower memory and processing speed scores in participants with metabolic syndrome. Overall, metabolic syndrome reshapes the brain's energetic landscape, accelerates functional brain aging, and selectively impairs memory-related networks. Network control theory-derived metrics offer a mechanistic and sensitive biomarker linking metabolic health to cognitive function. Central adiposity was the primary modifiable driver, underscoring the importance of early, targeted metabolic interventions to preserve network efficiency and cognitive resilience.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.